Suchergebnisse - "Itolizumab"

PubPharm (11)

1

Adverse drug reactions of itolizumab in COVID-19 patient : A case report

enthalten in: Indian journal of pharmacology | 2022

von Mohammed, Z. | Suryachandra, K. | Dandekar, M.

2

Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis : A Small Case Series Using Streptokinase

enthalten in: Seminars in thrombosis and hemostasis | 2021

von Caballero López, A. | Herrera Cartaya, C. | Chávez González, E. | +8

3

Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19

enthalten in: Indian journal of pharmacology | 2021

von Vityala, Y. | Tagaev, T. | Mamatov, S. | +2

4

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

enthalten in: Expert opinion on biological therapy | 2021

von Kumar, S. | De Souza, R. | Nadkar, M. | +7

5

Monoclonal Antibodies vs COVID-19 : Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center

enthalten in: MEDICC review | 2021

von Aguilar, T. | Gorry, C.

6

An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome : report of three cases

enthalten in: Immunotherapy | 2021

von Filgueira, L. | Cervantes, J. | Lovelle, O. | +14

7

Itolizumab Treatment for Cytokine Release Syndrome in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19 : Clinical Outcomes, A Retrospective Study

enthalten in: The Journal of the Association of Physicians of India | 2021

von Gore, V. | Kshirsagar, D. | Bhat, S. | +2

8

Approval of Itolizumab for COVID-19 : A Premature Decision or Need of The Hour?

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2020

von Atal, S. | Fatima, Z. | Balakrishnan, S.

9

Possible treatment and strategies for COVID-19 : review and assessment

enthalten in: European review for medical and pharmacological sciences | 2020

von Trivedi, N. | Verma, A. | Kumar, D.

10

Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications

enthalten in: Expert opinion on biological therapy | 2020

von Loganathan, S. | Athalye, S. | Joshi, S.